Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5268711
Max Phase: Preclinical
Molecular Formula: C34H58O10
Molecular Weight: 626.83
Associated Items:
ID: ALA5268711
Max Phase: Preclinical
Molecular Formula: C34H58O10
Molecular Weight: 626.83
Associated Items:
Canonical SMILES: CO[C@H]1[C@H](O[C@@H]2C=C3[C@H](O)C[C@@]4(O)[C@@H]5[C@@H](O)[C@H](O)[C@H]([C@H](C)CC[C@H](CO)C(C)C)[C@@]5(C)CC[C@@H]4[C@@]3(C)CC2)OC[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C34H58O10/c1-17(2)19(15-35)8-7-18(3)25-27(39)28(40)30-33(25,5)12-10-24-32(4)11-9-20(13-21(32)22(36)14-34(24,30)41)44-31-29(42-6)26(38)23(37)16-43-31/h13,17-20,22-31,35-41H,7-12,14-16H2,1-6H3/t18-,19-,20+,22-,23-,24-,25+,26+,27-,28+,29-,30-,31+,32+,33-,34+/m1/s1
Standard InChI Key: FAIKPJAKDAZGGB-HYMVMEEQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 626.83 | Molecular Weight (Monoisotopic): 626.4030 | AlogP: 1.75 | #Rotatable Bonds: 9 |
Polar Surface Area: 169.30 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.73 | CX Basic pKa: | CX LogP: 0.89 | CX LogD: 0.89 |
Aromatic Rings: 0 | Heavy Atoms: 44 | QED Weighted: 0.19 | Np Likeness Score: 2.98 |
1. Sasayama Y, Mamiya T, Qi J, Shibata T, Uchida K, Nabeshima T, Ojika M.. (2023) Neuritogenic steroid glycosides from crown-of-thorns starfish: Possible involvement of p38 mitogen-activated protein kinase and attenuation of cognitive impairment in senescence-accelerated mice (SAMP8) by peripheral administration., 78 [PMID:36577328] [10.1016/j.bmc.2022.117144] |
Source(1):